January 2, 2007
PerkinElmer Inc has signed an agreement with Euroscreen S.A. that entitles it to acquire Euroscreen Products S.A.
Euroscreen Products, Gosselies, Belgium, is a provider of G protein-coupled receptor (GPCR) membranes, cell lines, and the AequoScreen aequorin-based cellular assay platform used in pharmaceutical and biotech drug discovery laboratories. The transaction is expected to be completed in the first quarter of 2007.
Under the planned terms, Euroscreen Products would transfer its portfolio of GPCR screening tools and its exclusive global license of aequorin technology, granted by the University of Georgia Research Foundation Inc., to PerkinElmer. Aequorin technology is based on a naturally occurring photoprotein and generates large, luminescent signals that result in higher quality data, while reducing the number of false positives in high throughput and ultra-high throughput screening environments.
This announcement builds upon other recent news from PerkinElmer related to GPCR and kinase assay development. The Company announced its agreement to purchase Evotec Technologies, which provides high content screening (HCS) technologies to pharmaceutical and biotechnology drug discovery labs.
